Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0028-3908(93)90182-3PMID 8413838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?

  2005cited by this paper
• Kinetics of cholinesterase inhibition by eptastigmine in man

  2004cited by this paper
• Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum.

  1993cited by this paper
• Preferential inhibition of acetylcholinesterase molecular forms in rat brain

  1992cited by this paper
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

  1992cited by this paper
• Determination of Acetylcholine Release in the Striatum of Anesthetized Rats Using In Vivo Microdialysis and a Radioimmunoassay

  1991cited by this paper
• Determination of basal acetylcholine release in vivo by rat brain dialysis with a U-shaped cannula: effect of SM-10888, a putative therapeutic drug for Alzheimer's disease.

  1991cited by this paper
• The effect of acetylcholinesterase inhibition on the release of acetylcholine from the striatum in vivo: interaction with autoreceptor responses.

  1990cited by this paper
• Acetylcholine release in the rat hippocampus as studied by microdialysis is dependent on axonal impulse flow and increases during behavioural activation.

  1990cited by this paper
• Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

  1989cited by this paper
• The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat

  1989cited by this paper
• Basal acetylcholine release in freely moving rats detected by on-line trans-striatal dialysis: pharmacological aspects.

  1988cited by this paper
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• A long-lasting cholinesterase inhibitor affecting neural and behavioral processes.

  1987cited by this paper
• A Simple, Sensitive, and Economic Assay for Choline and Acetylcholine Using HPLC, an Enzyme Reactor, and an Electrochemical Detector

  1985cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Acetylcholine and Choline in Neuronal Tissue Measured by HPLC with Electrochemical Detection

  1983cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Physostigmine in Alzheimer's disease.

  1979cited by this paper
• A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations.

  1975cited by this paper
• Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.

  1973cited by this paper

• Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

  2019cites this paper
• An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function

  2014cites this paper
• A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.

  2013cites this paper
• Attenuation of scopolamine-induced cognitive dysfunction by obovatol

  2012cites this paper
• The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum.

  2012cites this paper
• Prolyl Oligopeptidase as a Drug Target

  2012cites this paper
• Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.

  2011cites this paper
• Cholinesterase inhibitors and beyond.

  2009cites this paper
• Attenuation of the blood flow response to physostigmine in the rat cortex deafferented from the basal forebrain.

  2007cites this paper
• Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.

  2004cites this paper
• Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease

  2004cites this paper
• T-588, a cognitive enhancer, stimulates in vivo phosphorylation of extracellular signal-regulated kinases in the hippocampus.

  2003cites this paper
• Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons.

  2003cites this paper
• Effects of cholinergic enhancement on conditioning‐related responses in human auditory cortex

  2002cites this paper
• Acetylcholinesterase Inhibition Increases in Vivo N-(2-[18F]Fluoroethyl)-4-piperidyl Benzilate Binding to Muscarinic Acetylcholine Receptors

  2001cites this paper
• Application of in vivo microdialysis to the study of cholinergic systems.

  2001cites this paper
• The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics

  2000cites this paper
• Acetylcholinesterase Inhibitors Are Neither Necessary nor Desirable for Microdialysis Studies of Brain Acetylcholine

  2000cites this paper
• Differentiated Cerebrovascular Effects of Physostigmine and Tacrine in Cortical Areas Deafferented from the Nucleus Basalis Magnocellularis Suggest Involvement of Basalocortical Projections to Microvessels

  2000cites this paper
• Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats.

  2000cites this paper
• A Prospective Study of Serum Pseudocholinesterase Levels in Patients With Chronic Spinal Pain: A Preliminary Study

  2000influential citation
• Effects of physostigmine and calcium on acetylcholine efflux from the hippocampus of freely moving rats as determined by in vivo microdialysis and a radioimmunoassay.

  2000cites this paper
• Effects of Cholinergic Drugs on Neocortical EEG and Flash-Visual Evoked Potentials in the Mouse

  1999cites this paper
• Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.

  1999cites this paper
• The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements.

  1999cites this paper
• Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

  1998cites this paper
• Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268).

  1998cites this paper
• Muscarinic Cholinergic Receptor Measurements with [18F]FP-TZTP: Control and Competition Studies

  1998cites this paper
• Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.

  1998cites this paper
• Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.

  1998cites this paper
• Imaging cholinergic function in vivo in the brain with radioiodinated stereoisomers of quinuclidinyl benzilate

  1998cites this paper
• Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe.

  1998cites this paper
• Cognitive functions of cortical acetylcholine: toward a unifying hypothesis.

  1997cites this paper
• Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats.

  1997cites this paper
• The brain cholinergic system as a target of cognition enhancers.

  1997cites this paper
• Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.

  1997cites this paper
• Repeated administration of tacrine to normal rats: effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography.

  1997cites this paper
• Acetylcholine Release in the Rat Prefrontal Cortex In Vivo: Modulation by α2‐Adrenoceptor Agonists and Antagonists

  1997cites this paper
• Diffuse transmission by acetylcholine in the CNS.

  1997cites this paper
• Acetylcholine release from frontal cortex in the waking rat measured by microdialysis without acetylcholinesterase inhibitors: effects of diisopropylfluorophosphate.

  1996cites this paper
• The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

  1996cites this paper
• Thermoregulatory Aspects of Environmental Exposure to Anticholinesterase Agents

  1996cites this paper
• Effects of MF‐268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex

  1996cites this paper
• Receptor regulation of cortical pyramidal neurone activity : implications for the treatment of Alzheimer's disease.

  1996cites this paper
• Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines

  1995cites this paper
• Cholinomimetics Increase Glutamate Outflow via an Action on the Corticostriatal Pathway: Implications for Alzheimer's Disease

  1995cites this paper
• Metrifonate effects on acetylcholine and biogenic amines in rat cortex

  1995cites this paper
• Effect of MDL 73,745 on acetylcholine and biogenic amine levels in rat cortex.

  1995cites this paper
• The alpha 2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo.

  1995cites this paper
• Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats

  1994cites this paper
• Thermoregulation in laboratory mammals and humans exposed to anticholinesterase agents.

  1994cites this paper
• Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.

  1994cites this paper
• Effect of NIK-247 on basal concentrations of extracellular acetylcholine in the cerebral cortex of conscious, freely moving rats.

  1994cites this paper
• Improved method for the routine analysis of acetylcholine release in vivo: quantitation in the presence and absence of esterase inhibitor.

  1993cites this paper